Meihao Medical Group Co., Ltd (HKG:1947)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Healthcare Facilities & Services	101.69M	74.68M	73.51M	127.41M	105.32M
Healthcare Facilities & Services Growth	36.16%	1.59%	-42.30%	20.98%	24.55%
Total	101.69M	74.68M	73.51M	127.41M	105.32M
Total Growth	36.16%	1.59%	-42.30%	20.98%	24.55%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Mainland China	101.69M	74.68M	73.51M	127.41M	105.32M
Mainland China Growth	36.16%	1.59%	-42.30%	20.98%	24.55%
Total	101.69M	74.68M	73.51M	127.41M	105.32M
Total Growth	36.16%	1.59%	-42.30%	20.98%	24.55%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 12, 2026

Data Sources Report a data error